D（6か月以上） 条件を付加する。<br>(1) 分与希望者は事前に 若松　佑子 (wakamatu@bio.nagoya-u.ac.jp) に連絡をとり、分与に関して許可を得ること。(2) 当該マウスを用いる論文発表に際してはAccession No. CDB0553K、そのWEB サイトhttp://www2.clst.riken.jp/arg/mutant%20mice%20list.htmlとともに当該マウスを記載すること。(3) 当該マウスを用いる論文発表に際しては、その由来として第一報論文 FEBS Lett. 2009 583(12):2108-13. を引用すること。（4）発表論文を寄託者（mutant.bdr@riken.jp）に連絡すること。 Glis3(-)(Acc.No. CDB0553K) Glis3(-)(Acc.No. CDB0553K) (1) The RECIPIENT shall obtain a prior agreement from Dr. Yuko Wkamatsu (wakamatu@bio.nagoya-u.ac.jp) to transfer the BIOLOGICAL RESOURCE. (2) In publishing the research results obtained by use of the BIOLOGICAL RESOURCE, a citation of the Accession No. (CDB0553K) (http://www2.clst.riken.jp/arg/mutant%20mice%20list.html) and the BIOLOGICAL RESOURCE is requested. (3) In publishing the research results obtained by use of the BIOLOGICAL RESOURCE, a citation of the literature designed by the DEPOSITOR is requested. (FEBS Lett. 2009 583(12):2108-13.) (4) Please inform the DEPOSITOR (mutant.bdr@riken.jp) about the paper when published. RIKEN CDB RIKEN CDB Glis3(-)(Acc.No. CDB0553K) TT2 [(C57BL/6NCrlj x CBA/JNCrlj)F1] true Necessary documents for ordering:<ol><li>Order form (<A HREF="https://mus.brc.riken.jp/ja/wp-content/uploads/form/form_4.docx">Japanese</A> / <A HREF="https://mus.brc.riken.jp/en/wp-content/uploads/form/form_b.docx">English</A>)</li><li>Category I MTA: MTA for distribution with RIKEN BRC (<A HREF="https://mus.brc.riken.jp/ja/wp-content/uploads/form/form_5.docx">Japanese</A> / <A HREF="https://mus.brc.riken.jp/en/wp-content/uploads/form/form_c.docx">English</A>)</li><li>Acceptance of responsibility for living modified organism (<A HREF="https://mus.brc.riken.jp/ja/wp-content/uploads/form/form_7.docx">Japanese</A> / <A HREF="https://mus.brc.riken.jp/en/wp-content/uploads/form/form_g.docx">English</A>)</li></ol> Neo(大腸菌), loxP(P1ファージ), PGKプロモーター,PGK３’end(マウス) D (more than 6 months) B6.Cg-Glis3<tm1Hiha>/Rbrc RBRC03521